CoChat

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches

Atreya, Chloe E., Yaeger, Rona, Chu, Edward · 2017 · American Society of Clinical Oncology Educational Book

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Over the past 20 years, substantial advances have been made in the treatment of patients with metastatic colorectal cancer (mCRC). In particular, there is now a wide range of options for the front-line treatment of mCRC. Sophisticated molecular technologies have been developed to identify novel prognostic and predictive biomarkers for CRC. DNA sequencing technology has made remarkable advances in recent years, primarily as a result of the development of next-generation sequencing and whole exome sequencing, which are powerful new tools for the discovery of predictive molecular biomarkers to facilitate the delivery of personalized medicine. In addition to tumor tissue, recent efforts have focused on analyzing circulating tumor DNA in peripheral blood. Herein, we review the evolution of standard chemotherapy and targeted therapy strategies for the treatment of mCRC in the front-line setting, the molecular technologies that are presently being used to facilitate our ability to practice individualized medicine, and the practical aspects of applying molecular biomarkers to everyday clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1200/edbk_175679

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 8

  1. Weinberg BA, 2016, Clin Adv Hematol Oncol, 14, 116
  2. Venook A, 2006, J Clin Oncol
  3. 10.1186/s13059-014-0454-7 · doi:10.1186/s13059-014-0454-7 · Paper page
  4. Raghav KPS, 2016, J Clin Oncol, 34
  5. Sartore-Bianchi A, 2015, J Natl Cancer Inst, 108, djv306
  6. Seligmann JF, Ann Oncol
  7. Sehdev A, 2016, Discov Med, 21, 341
  8. Corcoran R, 2016, Ann Onco, 27, vi1

Cited by

See all 42

Metadata

Authors
Atreya, C. E., Yaeger, R., & Chu, E.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Venue
American Society of Clinical Oncology Educational Book
Published
2017-05
Volume
37
Issue
37
Pages
246-256
ISSN
  • 1548-8748 (ISSN-L)
  • 1548-8756
OpenAlex
W4244654711
Cited by
35
References
66
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 1
FWCI
0.40
Type
journal article
Language
en
Open access
closed
Locations
  • American Society of Clinical Oncology Educational Book (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (K08CA175153)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
metastatic colorectal cancer, systemic therapy, first-line therapy, targeted therapy, predictive biomarkers, prognostic factors, next-generation sequencing, exome sequencing, circulating tumor DNA, personalized medicine, chemotherapy
MeSH terms
Humans, Neoplastic Cells, Circulating, Neoplasm Metastasis, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, Precision Medicine, Molecular Targeted Therapy, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.